Drugs / LDLA202
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01652898 | Jul 2012 | — | AOP Orphan Pharmaceuticals AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LDLA202 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01652898 ↗ |
| Route | Intravenous | “AOP LDLA202 administered as intravenous bolus injection” NCT01652898 ↗ |